These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
171 related articles for article (PubMed ID: 36452668)
21. Stromal and epithelial syndecan-1 expression in benign and malignant salivary gland tumors: which is more reflective of behavior? Alaeddini M; Yazdani F; Etemad-Moghadam S Braz J Otorhinolaryngol; 2021; 87(2):171-177. PubMed ID: 31540870 [TBL] [Abstract][Full Text] [Related]
22. Diagnostic Utility of Immunohistochemical Expressions of IMP3 Versus DOG1 and p63 in Salivary Gland Tumors. Ibrahim TR; Ahmed MM; Hegazy AA Turk Patoloji Derg; 2020; 36(3):227-236. PubMed ID: 32692399 [TBL] [Abstract][Full Text] [Related]
23. Hierarchical cluster analysis of myoepithelial/basal cell markers in adenoid cystic carcinoma and polymorphous low-grade adenocarcinoma. Prasad ML; Barbacioru CC; Rawal YB; Husein O; Wen P Mod Pathol; 2008 Feb; 21(2):105-14. PubMed ID: 18084258 [TBL] [Abstract][Full Text] [Related]
24. Comparison of p63 and p40 (ΔNp63) as Basal, Squamoid, and Myoepithelial Markers in Salivary Gland Tumors. Owosho AA; Aguilar CE; Seethala RR Appl Immunohistochem Mol Morphol; 2016 Aug; 24(7):501-8. PubMed ID: 26230372 [TBL] [Abstract][Full Text] [Related]
26. p63 expression in salivary gland tumors: role of DeltaNp73L in neoplastic transformation. Foschini MP; Gaiba A; Cocchi R; Pennesi MG; Pession A Int J Surg Pathol; 2005 Oct; 13(4):329-35. PubMed ID: 16273188 [TBL] [Abstract][Full Text] [Related]
27. Expression of TdT in Myoepithelial Cells: Investigation in Breasts, Sweat Glands, and Salivary Lesions Emphasizing the Never-Documented Immunohistochemical Findings. Zhou J; Xu H; Zeng H; Ma H; Yu J; Liu X; Sun Z; Zhou L; Zheng S; Wang X; Wang A; Wang C Int J Surg Pathol; 2020 Oct; 28(7):711-720. PubMed ID: 32362207 [No Abstract] [Full Text] [Related]
28. P63 is expressed in basal and myoepithelial cells of human normal and tumor salivary gland tissues. Bilal H; Handra-Luca A; Bertrand JC; Fouret PJ J Histochem Cytochem; 2003 Feb; 51(2):133-9. PubMed ID: 12533521 [TBL] [Abstract][Full Text] [Related]
29. Epithelial-myoepithelial carcinoma of the minor salivary glands: immunohistochemical and morphological features. Angiero F; Sozzi D; Seramondi R; Valente MG Anticancer Res; 2009 Nov; 29(11):4703-9. PubMed ID: 20032423 [TBL] [Abstract][Full Text] [Related]
30. Salivary gland-type tumors of the breast: a spectrum of benign and malignant tumors including "triple negative carcinomas" of low malignant potential. Foschini MP; Krausz T Semin Diagn Pathol; 2010 Feb; 27(1):77-90. PubMed ID: 20306833 [TBL] [Abstract][Full Text] [Related]
31. Immunohistochemical analysis of cathepsin-D in benign and malignant salivary gland neoplasms. Evaluation of its role as a prognostic indicator. Mohan M; Suresh R; Janardhanan M; Savithri V; Aravind T J Oral Maxillofac Pathol; 2022; 26(4):589. PubMed ID: 37082080 [TBL] [Abstract][Full Text] [Related]
32. Diagnostic utility of p63/p40 in the histologic differentiation of salivary gland tumors: A systematic review. Sivakumar N; Narwal A; Pandiar D; Devi A; Anand R; Bansal D; Kamboj M Oral Surg Oral Med Oral Pathol Oral Radiol; 2022 Feb; 133(2):189-198. PubMed ID: 34518135 [TBL] [Abstract][Full Text] [Related]
33. SOX10-positive salivary gland tumors: a growing list, including mammary analogue secretory carcinoma of the salivary gland, sialoblastoma, low-grade salivary duct carcinoma, basal cell adenoma/adenocarcinoma, and a subgroup of mucoepidermoid carcinoma. Hsieh MS; Lee YH; Chang YL Hum Pathol; 2016 Oct; 56():134-42. PubMed ID: 27327192 [TBL] [Abstract][Full Text] [Related]
34. Cytopathologic analysis of stroma-poor salivary gland epithelial/myoepithelial neoplasms on fine needle aspiration. Chen L; Ray N; He H; Hoschar A Acta Cytol; 2012; 56(1):25-33. PubMed ID: 22236742 [TBL] [Abstract][Full Text] [Related]
35. Sebaceous epithelial-myoepithelial carcinoma of the salivary gland: clinicopathologic and immunohistochemical analysis of 6 cases of a new histologic variant. Shinozaki A; Nagao T; Endo H; Kato N; Hirokawa M; Mizobuchi K; Komatsu M; Igarashi T; Yokoyama M; Masuda S; Sano K; Izumi M; Fukayama M; Mukai K Am J Surg Pathol; 2008 Jun; 32(6):913-23. PubMed ID: 18425042 [TBL] [Abstract][Full Text] [Related]
36. Characterisation of DOG-1 Expression in Salivary Gland Tumours and Comparison with Myoepithelial Markers. Khurram SA; Speight PM Head Neck Pathol; 2019 Jun; 13(2):140-148. PubMed ID: 29671211 [TBL] [Abstract][Full Text] [Related]
37. High-grade transformation/dedifferentiation of an adenoid cystic carcinoma of the minor salivary gland to myoepithelial carcinoma. Tando S; Nagao T; Kayano K; Fushiki S; Itoh K Pathol Int; 2018 Feb; 68(2):133-138. PubMed ID: 29287310 [TBL] [Abstract][Full Text] [Related]
38. Immunohistochemical study of salivary gland tumors in a tertiary institution in South-South Region of Nigeria. Omitola OG; Iyogun CA J Oral Maxillofac Pathol; 2018; 22(2):163-167. PubMed ID: 30158766 [TBL] [Abstract][Full Text] [Related]
39. Immunohistochemical detection of E-cadherin in certain types of salivary gland tumours. Andreadis D; Epivatianos A; Mireas G; Nomikos A; Poulopoulos A; Yiotakis J; Barbatis C J Laryngol Otol; 2006 Apr; 120(4):298-304. PubMed ID: 16623973 [TBL] [Abstract][Full Text] [Related]